Article info
PDFOvarian Cancer
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium
- Address correspondence and reprint requests to Amit M. Oza, MD, Princess Margaret Hospital, University of Toronto, Toronto, Ontario, Canada. E-mail: amit.oza{at}uhn.on.ca.
Citation
Sorafenib in Combination With Gemcitabine in Recurrent Epithelial Ovarian Cancer: A Study of the Princess Margaret Hospital Phase II Consortium
Publication history
- Received February 5, 2010
- First published June 1, 2010.
Online issue publication
March 06, 2019
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Copyright © 2010 by IGCS and ESGO